Keratinocytes synthesize enteropeptidase and multiple forms of trypsinogen during terminal differentiation

Journal of Investigative Dermatology

Volumn 130, Issue 4, 2010, Pages 944-952

  Nakanishi, Jotaro ^a   Yamamoto, Mami ^a,b   Koyama, Junichi ^a   Sato, Junko ^a   Hibino, Toshihiko ^a  

^a SHISEIDO RESEARCH CENTER   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENTEROPEPTIDASE; MESSENGER RNA; TRYPSINOGEN; TRYPSINOGEN 1; TRYPSINOGEN 2; TRYPSINOGEN 3; TRYPSINOGEN 4; TRYPSINOGEN 5; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME LOCALIZATION; ENZYME SYNTHESIS; EPIDERMIS; EXON; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MOLECULAR CLONING; NICK END LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

EID: 77949518419     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.364     Document Type: Article

References (40)

1. Abita JP, Delaage M, Lazdunski M et al. (1969) The mechanism of activation of trypsinogen. The role of the four N-terminal aspartyl residues. Eur J Biochem 8:314-324
2. Amano S, Akutsu N, Matsunaga Y et al. (2001) Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation. Exp Cell Res 271:249-262
3. Anderson LE, Walsh KA, Neurath H (1977) Bovine enterokinase. Purification, specificity, and some molecular properties. Biochemistry 16:3354-3360
4. Borgono CA, Michael IP, Komatsu N et al. (2007) A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 282:3640-3652
5. Bowden PE, Quinlan RA, Breitkreutz D et al. (1984) Proteolytic modification of acidic and basic keratins during terminal differentiation of mouse and human epidermis. Eur J Biochem 142:29-36
6. Brattsand M, Egelrud T (1999) Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 274:30033-30040
7. Brattsand M, Stefansson K, Lundh C et al. (2005) A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 124:198-203
8. Bricteux-Gregoire S, Schyns R, Florkin M (1971) N-terminal amino acid sequence of dromedary trypsinogen. Biochim Biophys Acta 251:79-82
9. Caubet C, Jonca N, Brattsand M et al. (2004) Degradation of corneodesmo-some proteins by two serine proteases of the kallikrein family, SCTE/ KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122:1235-1244
10. Chavanas S, Bodemer C, Rochat A et al. (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141-142
11. Clements J, Hooper J, Dong Y et al. (2001) The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Biol Chem 382:5-14
12. Descargues P, Deraison C, Bonnart C et al. (2005) Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 37:56-65
13. Egelrud T (1993) Purification and preliminary characterization of stratum corneum chymotryptic enzyme: a proteinase that may be involved in desquamation. J Invest Dermatol 101:200-204
14. Egelrud T, Lundstrom A (1991) A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum. Arch Dermatol Res 283:108-112
15. Ekholm IE, Brattsand M, Egelrud T (2000) Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 114:56-63
16. Fartasch M (1997) Epidermal barrier in disorders of the skin. Microsc Res Tech 38:361-372
17. Fleckman P, Dale BA, Holbrook KA (1985) Profilaggrin, a high-molecular-weight precursor of filaggrin in human epidermis and cultured keratinocytes. J Invest Dermatol 85:507-512
18. Fuchs E, Green H (1980) Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19:1033-1042
19. Hachem JP, Wagberg F, Schmuth M et al. (2006) Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 126:1609-1621
20. Hansson L, Stromqvist M, Backman A et al. (1994) Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem 269:19420-19426
21. Harvey TJ, Hooper JD, Myers SA et al. (2000) Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J Biol Chem 275:37397-37406
22. Komatsu N, Saijoh K, Toyama T et al. (2005) Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br J Dermatol 153:274-281
23. Koshikawa N, Nagashima Y, Miyagi Y et al. (1997) Expression of trypsin in vascular endothelial cells. FEBS Lett 409:442-448
24. Langley RG, Krueger GG, Griffiths CE (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64(Suppl 2):ii18-23
25. Light A, Janska H (1989) Enterokinase (enteropeptidase): comparative aspects. Trends Biochem Sci 14:110-112
26. Lundstrom A, Egelrud T (1990) Cell shedding from human plantar skin in vitro: evidence that two different types of protein structures are degraded by a chymotrypsin-like enzyme. Arch Dermatol Res 282:234-237
27. Menon GK, Ghadially R, Williams ML et al. (1992) Lamellar bodies as delivery systems of hydrolytic enzymes: implications for normal and abnormal desquamation. Br J Dermatol 126:337-345
28. Nyaruhucha CN, Kito M, Fukuoka SI (1997) Identification and expression of the cDNA-encoding human mesotrypsin(ogen), an isoform of trypsin with inhibitor resistance. J Biol Chem 272:10573-10578
29. Rinderknecht H, Renner IG, Abramson SB et al. (1984) Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 86:681-692
30. Sahin-Toth M (2005) Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction. Protein Pept Lett 12:457-464
31. Schechter NM, Choi EJ, Wang ZM et al. (2005) Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI). Biol Chem 386:1173-1184
32. Sondell B, Thornell LE, Egelrud T (1995) Evidence that stratum corneum chymotryptic enzyme is transported to the stratum corneum extracellular space via lamellar bodies. J Invest Dermatol 104:819-823
33. Suzuki Y, Koyama J, Moro O et al. (1996) The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br J Dermatol 134:460-464
34. Suzuki Y, Nomura J, Hori J et al. (1993) Detection and characterization of endogenous protease associated with desquamation of stratum corneum. Arch Dermatol Res 285:372-377
35. Suzuki Y, Nomura J, Koyama J et al. (1994) The role of proteases in stratum corneum: involvement in stratum corneum desquamation. Arch Derma-tol Res 286:249-253
36. Szmola R, Kukor Z, Sahin-Toth M (2003) Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J Biol Chem 278:48580-48589
37. Tsunenaga M, Adachi E, Amano S et al. (1998) Laminin 5 can promote assembly of the lamina densa in the skin equivalent model. Matrix Biol 17:603-613
38. Wiegand U, Corbach S, Minn A et al. (1993) Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. Gene 136:167-175
39. Yahagi N, Ichinose M, Matsushima M et al. (1996) Complementary DNA cloning and sequencing of rat enteropeptidase and tissue distribution of its mRNA. Biochem Biophys Res Commun 219:806-812
40. Yousef GM, Scorilas A, Magklara A et al. (2000) The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family-genomic characterization, mapping, tissue expression and hormonal regulation. Gene 254:119-128